<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmacology / Pharmaceuticals policy / Epidemiology / Drug discovery / Rare Disease Day / Rare disease / Prescription Drug User Fee Act / National Organization for Rare Disorders / Health / Medicine / Pharmaceutical sciences
Date: 2012-12-18 11:57:21
Food and Drug Administration
Pharmacology
Pharmaceuticals policy
Epidemiology
Drug discovery
Rare Disease Day
Rare disease
Prescription Drug User Fee Act
National Organization for Rare Disorders
Health
Medicine
Pharmaceutical sciences

News from Nord An update for our members and friends SUMMER[removed]NORD Hails FDA Safety

Add to Reading List

Source URL: www.rarediseases.org

Download Document from Source Website

File Size: 1,38 MB

Share Document on Facebook

Similar Documents

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

DocID: 1t0K4 - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1  Basic PDUFA Construct

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct

DocID: 1sUEh - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016  Page 1 1  FOOD AND DRUG ADMINISTRATION (FDA)

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA)

DocID: 1sUz3 - View Document

United States Government Accountability Office  GAO Testimony Before the Subcommittee on Oversight

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

DocID: 1rfHg - View Document

Best Practices in Developing Proprietary Names for Drugs

Best Practices in Developing Proprietary Names for Drugs

DocID: 1r8R5 - View Document